- US-listed companies
- Finch Therapeutics Group, Inc.
- Balance sheet
Finch Therapeutics Group, Inc. (FNCHQ) Balance sheet
Market cap
$13.27M
P/E ratio
| 2021/12 | 2022/12 | 2023/12 | |
| Cash and cash equivalents | 134 | 71 | 25 |
| Total cash & short-term investments | 134 | 71 | 25 |
| Accounts receivable, net | 0 | 0 | - |
| Total current assets | 143 | 75 | 26 |
| Property, plant and equipment, net | 20 | 16 | 1 |
| Total non-current assets | 83 | 88 | 30 |
| Total assets | 225 | 163 | 55 |
| Accounts payable | 4 | 1 | 0 |
| Total current liabilities | 15 | 15 | 4 |
| Long-term debt, non-current | - | 15 | - |
| Total non-current liabilities | 8 | 53 | 28 |
| Total liabilities | 23 | 67 | 32 |
| Common stock and paid-in capital | 0 | 0 | 0 |
| Retained earnings | -161 | -276 | -350 |
| Stockholders' equity | 202 | 96 | 23 |
| Total debt | - | 15 | - |
| Net debt | - | -56 | - |
| D/E ratio (%) | - | 15.3 | - |